Last reviewed · How we verify

NCT07386964

Radicle Clarity CNM™: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes Among E-Gamers

Not yet recruiting NA Last updated 4 February 2026
What this trial tests

NA trial testing Clarity Product Placebo Control in Cognitive Function in 600 participants. Not yet recruiting.

Timeline
26 February 2026
Primary endpoint
26 February 2027
26 February 2027

Quick facts

Lead sponsorRadicle Science
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment600
Start date26 February 2026
Primary completion26 February 2027
Estimated completion26 February 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Radicle Science — full company profile →

Who can join

Adults 21 to 45, any sex, with Cognitive Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radicle Clarity CNM™: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on cognitive function and related health outcomes among E-Gamers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Clarity Active Product

Trials testing the same drug.

Other recruiting trials for Cognitive Function

Currently open trials in the same condition.

Other Radicle Science trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07386964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing